Global House Dust Mite Allergy Market – Industry Trends and Forecast to 2030

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global House Dust Mite Allergy Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global House Dust Mite Allergy Treatment Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1.88 Billion
Diagram Market Size (Forecast Year)
USD 5.00 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Shionogi & Co. Ltd
  • Stallergenes Greer
  • Merck & Co.
  • Torii Pharmaceutical Co. Ltd
  • Ergomed plc

Global House Dust Mite Allergy Market, By Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

House Dust Mite Allergy Market

House Dust Mite Allergy Market Analysis and Size

As per WHO records of all types of respiratory allergies, around 70% allergic reactions are related with house dust mites. The incidence of allergic rhinitis accounts for approximately 10-25%, globally. Additionally, as per the World Health Organization (WHO), in 2020, it was reported that about 70% of allergic reactions are caused because of house dust mite allergen.

Data Bridge Market Research analyses a growth rate in house dust mite allergy market in the forecast period 2023-2030. The expected CAGR of house dust mite allergy market is tend to be around 13% in the mentioned forecast period. The market was valued at USD 1.88 billion in 2022, and it would grow upto USD 5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

House Dust Mite Allergy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023-2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Shionogi & Co., Ltd (Japan), Stallergenes Greer (Switzerland), Merck & Co., Inc (U.S.), Torii Pharmaceutical Co.,Ltd (Japan), Ergomed plc (U.K.), Allergy Therapeutics (U.K.), DMS Imaging (Belgium), HAL Allergy B.V (Netherlands), Trio Lifescience Private Limited (India), Teva Pharmaceutical Industries Ltd (Israel), ICB PHARMA (Poland), Bayer AG (Germany), Sanofi (France), Catalent, Inc (India), GSK Plc. (U.K.), Merz Pharma (Germany)

Market Opportunities

  • Growing Demand of Prescription-Based Drugs

Market Definition

Dust mite allergy is a type of allergic reaction caused by dust mites present in house environments. House dust mites are tiny bugs with a very adaptive habitat and can survive in any climatic condition. Some people with strong immune systems do not respond to these mites, but people affected by these witness symptoms such as hay running nose, cough, fever, and others. Numerous people also experience conditions such as sinus infections, allergy rhinitis, and asthma.

House Dust Mite Allergy Market Dynamics

Drivers

  • Increasing Drug Approvals

There are different drug approvals by different drug organizations that are helping in boosting the market growth. For instance, in February 2018, Stallergenes Greer and Shionogi & Co., Ltd. received the marketing approval of Actair. It is an allergy immunotherapy drug used to treat house dust mite (HDM) induced allergic rhinitis in Japan. Stallergenes Greer partnered with Shionogi & Co., Ltd. and announced New Drug Application submission for the drug in January 2017. This approval will provide an effective treatment for house dust mite (HDM) induced allergic rhinitis in Japan and will enlarge the business of both the pharmaceutical companies. Furthermore, Merck & Co., Inc. received the U. S. FDA approval in 2017 for Odactra, an anti-allergy drug used to treat house dust mite-induced nasal inflammation in adults. The drug is widely available in oral dosage form and is administered sublingually. This novel drug will deliver a quality treatment to people suffering from house dust mite induced rhinitis and enlarges the business of the company.  

Opportunities

  •  Growing Demand of Prescription-Based Drugs

The prescription-based drugs increase the market growth resulting in nearly three-fifths of the market, and is expected to maintain its leadership status during the forecast period 2023-2030, due to increase in occurrence of house dust mite allergy diseases and numerous initiatives taken by government and private organizations to spread awareness about different allergic diseases.

 Restraints/Challenges

  • Side Effects of House dust mite allergy

Drugs of this condition have numerous side effects such as rash, transient fever, edema, and other problems. This hampers the market growth.

  • Discontinuation of Drug Trials

The drug development for the disease has faced major obstacles as numerous therapies have failed to demonstrate efficacy or were associated with major toxicity. Thus, this hampers the growth of the market.

This house dust mite allergy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the house dust mite allergy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global House Dust Mite Allergy Market

The outbreak of the Covid-19 pandemic has had an affirmative impact on the house dust mite allergy treatment market, due to the implementation of the global lockdown. All of the people were forced to stay at home for much longer, increasing the exposure to indoor pollutant. This in turn, increased the demand for house dust mite allergy treatment.

Global House Dust Mite Allergy Market Scope

The house dust mite allergy market is segmented on the basis of diagnosis, therapy type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

  • Skin Prick Test (SPT)
  • Specific IgE Blood Test
  • Others

Therapy Type

  • Medication
  • Antihistamines
  • Corticosteroids
  • Leukotriene Modifiers
  • Others
  • Immunotherapy
  • Nasal Irrigation
  • Others

Route of Administration

  • Oral
  • Nasal
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

 House Dust Mite Allergy Market Regional Analysis/Insights

The house dust mite allergy market is analyzed and market size insights and trends are provided by diagnosis, therapy type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the house dust mite allergy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be expecting positive growth for house dust mite allergy market throughout the forecasted period due to surge in incidence of house dust mite allergy diseases, increase in awareness about spreading knowledge regarding allergens, increase in healthcare expenditure, and rising adoption of immunotherapy drugs for the treatment of house dust mite allergies. 

North America dominates the market due to increase in occurrence of asthma & allergic rhinitis, growth in number of in-house dust pollution, presence of key players, and development in increase in R&D activities in the pharmaceutical sector in the region. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global House Dust Mite Allergy Market Share Analysis

The house dust mite allergy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to house dust mite allergy market.

Key players operating in the house dust mite allergy market include:

  • Shionogi & Co., Ltd (Japan)
  • Stallergenes Greer (Switzerland)
  • Merck & Co., Inc (U.S.)
  • Torii Pharmaceutical Co.,Ltd (Japan)
  • Ergomed plc (U.K.)
  • Allergy Therapeutics (U.K.)
  • DMS Imaging (Belgium)
  • HAL Allergy B.V (Netherlands)
  • Trio Lifescience Private Limited (India)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • ICB PHARMA (Poland)
  • Bayer AG (Germany)
  • Sanofi (France)
  • Catalent, Inc (India)
  • GSK Plc. (U.K.)
  • Merz Pharma (Germany)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global House Dust Mite Allergy Market, By Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030. .
The Global House Dust Mite Allergy Treatment Market size was valued at USD 1.88 USD Billion in 2022.
The Global House Dust Mite Allergy Treatment Market is projected to grow at a CAGR of 13% during the forecast period of 2023 to 2030.
The major players operating in the market include Shionogi & Co. Ltd, Stallergenes Greer, Merck & Co. , Torii Pharmaceutical Co. Ltd, Ergomed plc, Allergy Therapeutics, DMS Imaging, HAL Allergy B.V, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd, ICB PHARMA, Bayer AG, Sanofi, Catalent , GSK Plc, Merz Pharma.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.